Verified Nov 2026
Other
·

Boston, Massachusetts
·
Since 2018
Servier Pharmaceuticals is a privately held biotech company headquartered in Boston, Massachusetts, founded in 2018 and employing 1,000–5,000 people. A subsidiary of the global Servier Group, it develops precision therapeutics for oncology and neurology, with a focus on rare diseases and unmet medical needs. The company completed the acquisition of Day One Biopharmaceuticals in April 2026 and agreed to acquire Edgewise Therapeutics' muscular dystrophy business in June 2026.
Servier Pharmaceuticals at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
2018
Headquarters
Boston, Massachusetts
Certifications
ISO 14001 · ISO 45001 · ISO 50001 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
8 years in operation (founded 2018).
Holds ISO 14001, ISO 45001, ISO 50001, ISO 9001 certification(s) per public sources.
Overview
Servier Pharmaceuticals is a privately held biotech company headquartered in Boston, Massachusetts, founded in 2018 and employing 1,000–5,000 people. A subsidiary of the global Servier Group, it develops precision therapeutics for oncology and neurology, with a focus on rare diseases and unmet medical needs. The company completed the acquisition of Day One Biopharmaceuticals in April 2026 and agreed to acquire Edgewise Therapeutics' muscular dystrophy business in June 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | Boston, Massachusetts |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Certifications | ISO 14001 · ISO 45001 · ISO 50001 · ISO 9001 |
What Servier Pharmaceuticals makes
The company holds ISO 9001, ISO 14001, ISO 45001, and ISO 50001 certifications and manufactures small-molecule therapeutics targeting IDH mutant cancers including Acute Myeloid Leukemia, Myelodysplastic Syndromes, glioma, and Cholangiocarcinoma.
Certifications
Servier Pharmaceuticals is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — cphi-online.com
ISO 45001 — sgs.com
ISO 50001 — sgs.com
ISO 9001 — cphi-online.com
Latest developments
2026-06-01 — Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business (newswire.ca)
2026-04-23 — Servier completes the acquisition of Day One Biopharmaceuticals (servier.com)
2026-03-06 — Servier and Day One Biopharmaceuticals announce acquisition (servier.com)
2026-02-10 — French drugmaker Servier bets big on India as key global export hub | Company News - Business Standard (business-standard.com)
2026-01-27 — Servier delivers solid performance in 2024/25 (servier.com)
2026-01-12 — Biotech company Servier launches $234m venture fund - Global Venturing (globalventuring.com)
Company details
Servier is a privately held subsidiary of the global Servier Group with revenues estimated between $1–5 billion and operates across oncology research, drug formulation, and distribution. Servier Pharmaceuticals was founded in 2018, has an estimated 1,000-5,000 employees, and is headquartered in Boston, Massachusetts. On the LightSource stability read it is rated "Established & active": 8 years in operation (founded 2018). Holds ISO 14001, ISO 45001, ISO 50001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Servier Pharmaceuticals do?
Servier Pharmaceuticals is a privately held biotech company headquartered in Boston, Massachusetts, founded in 2018 and employing 1,000–5,000 people. A subsidiary of the global Servier Group, it develops precision therapeutics for oncology and neurology, with a focus on rare diseases and unmet medical needs. The company completed the acquisition of Day One Biopharmaceuticals in April 2026 and agreed to acquire Edgewise Therapeutics' muscular dystrophy business in June 2026.
Where is Servier Pharmaceuticals headquartered?
Servier Pharmaceuticals is headquartered in Boston, Massachusetts (198 Pier 4 Blvd, Boston, Massachusetts, 02210).
When was Servier Pharmaceuticals founded?
Servier Pharmaceuticals was founded in 2018.
How big is Servier Pharmaceuticals?
Servier Pharmaceuticals has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
What certifications does Servier Pharmaceuticals hold?
Servier Pharmaceuticals lists ISO 14001 · ISO 45001 · ISO 50001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+33 1 55 72 60 00
Certification
ISO 14001 · ISO 45001 · ISO 50001 · ISO 9001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
